How much funding has Valence Discovery raised?

Valence Discovery has raised $25.0M in total funding, most recently a Series B round.

Who are Valence Discovery's investors?

Valence Discovery's investors include Insight Partners, Bessemer VP, Air Street Capital, Jonathan Milner, Fifty Years, FirstMark Capital.

When was Valence Discovery founded?

Valence Discovery was founded in 2018.

Where is Valence Discovery headquartered?

Valence Discovery is headquartered in Montréal, Quebec, Canada.

What industry is Valence Discovery in?

Valence Discovery operates in Artificial Intelligence, Data & Analytics, Healthcare, Biotech.

How many employees does Valence Discovery have?

Valence Discovery has 51-200 employees.

Valence Discovery

formerly Valence LabsAcquired

AI drug discovery with graph neural networks

Montréal, Canada · Founded 2018 · $25.0M raised

Artificial Intelligence

Data & Analytics

Healthcare

Biotech

Headquarters: Montréal, Quebec
Employees: 51–200
Founded: 2018
Business Model: B2B

Website: valencediscovery.com
Total Funding: $25.0M
Last Round: $16.5M Series BSep 2025
Rounds: 4

About

Montreal-based AI drug discovery company (acquired by Recursion Pharmaceuticals in May 2023 for $47.5M USD). Valence Labs, the rebranded research engine, develops graph neural network (GNN) foundation models for molecular property prediction and drug discovery. The company built MolGPS, a 3-billion parameter GNN model trained on 5+ million molecules, achieving state-of-the-art performance on ADMET (absorption, distribution, metabolism, excretion, toxicity), binding prediction, and molecular design benchmarks.

Summary

Valence Discovery is an Artificial Intelligence company based in Montréal, Canada, founded in 2018. It has raised $25.0M in total across 4 rounds, most recently a $16.5M Series B round in Sep 2025. Investors include Insight Partners, Bessemer VP and Air Street Capital.